Traws Pharma, Inc.
TRAW · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13 | $21 | $17 | $21 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $2 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $1 |
| Other Curr. Assets | $1 | $2 | $2 | $0 |
| Total Curr. Assets | $15 | $25 | $19 | $23 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $16 | $25 | $19 | $23 |
| Liabilities | – | – | – | – |
| Payables | $5 | $8 | $6 | $6 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $3 | $4 | $3 |
| Total Curr. Liab. | $7 | $12 | $10 | $9 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $3 | $3 | $3 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $42 | $112 | $0 |
| Total NC Liab. | $0 | $45 | $114 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7 | $57 | $124 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$629 | -$649 | -$611 | -$483 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $637 | $618 | $505 | $493 |
| Total Equity | $8 | -$32 | -$106 | $11 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $16 | $25 | $19 | $23 |
| Net Debt | -$13 | -$21 | -$17 | -$21 |